Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDER`S EQUITY (UNAUDITED)

v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDER`S EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Oct. 31, 2017 $ 166,028 $ 163,931,079 $ (156,174,184) $ 7,922,923   $ 7,922,923
Balance (in Shares) at Oct. 31, 2017 16,602,759          
Stock option compensation to employees and directors   472,532   472,532   472,532
Stock option compensation to consultants   126,151   126,151   126,151
Common stock issued upon exercise of stock options $ 398 (398)        
Common stock issued upon exercise of stock options (in Shares) 39,816          
Common stock issued to consultants $ 53 14,949   15,002   15,002
Common stock issued to consultants (in Shares) 5,347          
Common stock issued in at-the-market offering, net of offering expenses of $152,911/$82,942 $ 2,025 675,345   677,370   677,370
Common stock issued in at-the-market offering, net of offering expenses of $152,911/$82,942 (in Shares) 202,523          
Issuance of noncontrolling interest in Certainty Therapeutics, Inc   68,974   68,974 $ (4,318) 64,656
Net loss     (3,216,606) (3,216,606) (41,382) (3,257,988)
Balance at Apr. 30, 2018 $ 168,504 165,288,632 (159,390,790) 6,066,346 (45,700) 6,020,646
Balance (in Shares) at Apr. 30, 2018 16,850,445          
Balance at Oct. 31, 2018 $ 189,086 175,415,931 (170,170,209) 5,434,808 (251,377) 5,183,431
Balance (in Shares) at Oct. 31, 2018 18,908,632          
Stock option compensation to employees and directors   2,024,664   2,024,664   2,024,664
Stock options and warrants issued to consultants   92,509   92,509   92,509
Common stock issued upon exercise of stock options $ 300 79,500   79,800   79,800
Common stock issued upon exercise of stock options (in Shares) 30,000          
Restricted stock award compensation to employee pursuant to stock incentive plan   1,954,441   1,954,441   1,954,441
Common stock issued pursuant to employee stock purchase plan $ 54 18,506   18,560   18,560
Common stock issued pursuant to employee stock purchase plan (in Shares) 5,411          
Common stock issued in at-the-market offering, net of offering expenses of $152,911/$82,942 $ 10,610 4,347,193   4,357,803   4,357,803
Common stock issued in at-the-market offering, net of offering expenses of $152,911/$82,942 (in Shares) 1,061,032          
Net loss     (7,419,533) (7,419,533) (122,010) (7,541,543)
Balance at Apr. 30, 2019 $ 200,050 $ 183,932,744 $ (177,589,742) $ 6,543,052 $ (373,387) $ 6,169,665
Balance (in Shares) at Apr. 30, 2019 20,005,075